By Corrie Driebusch
The Dow Jones Industrial Average eked out a fresh record high on
Wednesday in quiet trading following uneventful testimony from
Federal Reserve Chairwoman Janet Yellen.
The Dow industrials rose 15.38 points, or 0.1%, to 18224.57. The
S&P 500 slipped 1.62 points, or 0.1%, to 2113.86.
The Nasdaq Composite declined 0.98 point, or 0.02%, to 4967.14,
snapping a ten-session streak of gains. The index remains within
striking distance of 5000, a level last hit roughly 15 years
ago.
On Wednesday, traders watched Ms. Yellen's congressional
testimony, parsing it for clues about when and how fast interest
rates will rise, but her comments did not include any
surprises.
"Everybody's just trying to figure out what the Fed is going to
do. That's kind of the biggest topic on peoples' minds, especially
domestically," said R.J. Grant, associate director of equity
trading at KBW Inc.
In her Tuesday testimony, Ms. Yellen indicated the central bank
is moving toward raising interest rates later this year as the
economy has improved, and stocks pushed to record highs after these
comments. On Wednesday, she repeated her message.
Even as stocks climbed to fresh highs in recent sessions,
trading volumes have been low. In January, large intraday swings in
stocks were common in daily trading, often driven by moves in oil
prices, foreign currencies as well as concerns about Europe.
Trading on Wednesday was relatively slow, with no headlines to spur
a big market move.
The Chicago Board Options Exchange Volatility Index, or VIX, hit
a new 2015 low. The index, which measures expectations for swings
in the S&P 500 and is commonly considered a fear gauge of
financial markets, ended 1.1% higher at 13.84 for the day.
"If you're a mountain climber, as you get to the icier peaks,
you have to go more slowly; that's why markets tend to move higher
much more carefully than they go lower," said David Kelly, chief
global strategist for J.P. Morgan Asset Management. He said he
anticipated the grind higher to continue.
"The reality is that cash is paying nothing, fixed income is
unattractive, therefore money will move toward equities," he
said.
Among the gainers on Wednesday were biotech companies, a sector
that has posted strong gains over the past month as investors
searched for growth stocks.
"You keep seeing more and more noise around M&A in the
biotech space," said Ian Winer, head of equities trading at Wedbush
Securities, referring to a media report Wednesday that
Pharmacyclics Inc. was considering a sale, as well as more broadly
to the recent news that Valeant Pharmaceuticals International Inc.
will buy Salix Pharmaceuticals Ltd .
The SPDR S&P Biotech ETF is up 9% in the past month,
compared with the S&P 500's 3% gain in the same period.
In commodity markets, crude-oil futures snapped a five-session
losing streak, rising 3.5% to $50.99 a barrel. Gold futures added
0.3% to $1201.00 an ounce.
Action was muted in the Treasury market, with the 10-year note
yield declining to 1.968% from 1.987% on Tuesday. Bond yields fall
as prices rise.
New-home sales fell slightly in January but the overall pace
remained near a six-year high. Sales of newly built, single-family
homes decreased 0.2% from a month earlier, according to the
Commerce Department, a smaller decline than economists surveyed by
The Wall Street Journal had expected.
In corporate news, Hewlett-Packard Co. said its earnings for the
January quarter fell 4.1% as sales of desktop computers declined
sharply from a year ago and the company's revenue growth slowed
across its different segments. Shares fell 9.9%.
Chesapeake Energy Corp. said it would reduce its rig operations
to the lowest level since 2004, after higher production volume was
unable to offset lower prices in the fourth quarter, leading to
weaker-than-expected earnings. Shares fell 9.6%.
European stocks fell modestly. France's CAC 40 slipped 0.1% and
Germany's DAX closed roughly flat. The U.K.'s FTSE 100 declined
0.2%, pulling back from an all-time high.
Write to Corrie Driebusch at corrie.driebusch@wsj.com
Access Investor Kit for Fresenius Medical Care AG & Co.
KGaA
Visit
http://www.companyspotlight.com/partner?cp_code=P479&isin=DE0005785802
Access Investor Kit for Bayer AG
Visit
http://www.companyspotlight.com/partner?cp_code=P479&isin=DE000BAY0017
Access Investor Kit for A.P. Møller-Maersk A/S
Visit
http://www.companyspotlight.com/partner?cp_code=P479&isin=DK0010244425
Access Investor Kit for A.P. Møller-Maersk A/S
Visit
http://www.companyspotlight.com/partner?cp_code=P479&isin=DK0010244508
Access Investor Kit for A.P. Møller-Maersk A/S
Visit
http://www.companyspotlight.com/partner?cp_code=P479&isin=US00202F1021
Access Investor Kit for Bayer AG
Visit
http://www.companyspotlight.com/partner?cp_code=P479&isin=US0727303028
Access Investor Kit for Chesapeake Energy Corp.
Visit
http://www.companyspotlight.com/partner?cp_code=P479&isin=US1651671075
Access Investor Kit for The Dow Chemical Co.
Visit
http://www.companyspotlight.com/partner?cp_code=P479&isin=US2605431038
Access Investor Kit for Fresenius Medical Care AG & Co.
KGaA
Visit
http://www.companyspotlight.com/partner?cp_code=P479&isin=US3580291066
Access Investor Kit for Hewlett-Packard Co.
Visit
http://www.companyspotlight.com/partner?cp_code=P479&isin=US4282361033